Footprint analysis of estrogen receptor binding to adjacent estrogen response elements

Journal of Steroid Biochemistry and Molecular Biology

Volumn 58, Issue 1, 1996, Pages 45-61

  Driscoll, Mark D ^a   Klinge, Carolyn M ^a,b   Hilf, Russell ^a   Bambara, Robert A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; TAMOXIFEN AZIRIDINE; TAMOXIFEN DERIVATIVE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CATTLE; CONTROLLED STUDY; DNA FOOTPRINTING; DRUG RECEPTOR BINDING; FEMALE; NONHUMAN; UTERUS;

EID: 0030130436     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(96)00015-5     Document Type: Article

References (57)

1. 1. Klinge C.M., Bambara R.A. and Hilf R. (1992) What differentiates antiestrogen-liganded versus estradiol-liganded estrogen receptor action? Oncology Res. 4, 137-144.
2. 2. Parker M. G. and Bakker O.: Nuclear hormone receptors: concluding remarks. In: Nuclear Hormone Receptors (Edited by M. Parker). Academic Press, New York (1991) 377-395.
3. 3. Gronemeyer H. (1993) Transcription activation by nuclear receptors. J. Receptor Res. 13, 667-691.
4. 4. Klinge C.M., Bambara R.A. and Hilf R. (1992) Antiestrogen liganded estrogen receptor interaction with estrogen responsive element DNA in vitro. J. Steroid Biochem. Molec. Biol. 43, 249-262.
5. 5. Anolik J.H., Klinge C.M., Hilf R. and Bambara R.A. (1995) Cooperative binding of estrogen receptor to DNA depends on spacing of binding sites, flanking sequence, and ligand. Biochemistry 34, 2511-2520.
6. 6. Tsai S.Y., Tsai M.A. and O'Malley B.W. (1989) Cooperative binding of steroid hormone receptors contributes to transcriptional synergism at target enhancer elements. Cell 57, 443-448.
7. 7. Poellinger L., Yoza B.K. and Roeder R.G. (1989) Functional cooperativity between protein molecules bound at two distinct sequence elements of the immunoglobulin heavy-chain promoter. Nature 337, 573-576.
8. 8. Schmid W., Strahle U., Schutz G., Schmitt J. and Stunnenberg H. (1989) Glucocorticoid receptor binds cooperatively to adjacent recognition sites. EMBO J. 8, 2257-2263.
9. 9. Davidson I., Xiao J.H., Rosales R., Staub A. and Chambon R. (1988) The HeLa cell protein TEF-1 binds specifically and cooperatively to two SV40 enhancer motifs of unrelated sequence. Cell 54, 931-942.
10. 10. LeBowitz J.H., Clere R.G., Brenowitz M. and Sharp P. (1989) The Oct-2 protein binds cooperatively to adjacent octamer sites. Genes Dev. 3, 1625-1638.
11. 11. Martinez E. and Wahli W. (1989) Cooperative binding of estrogen receptor to imperfect estrogen-responsive DNA elements correlates with their synergistic hormone-dependent enhancer activity. EMBO J. 8, 3781-3791.
12. 12. Hochschild A. and Ptashne M. (1986) Homologous interactions of lambda repressor and lambda Cro with the lambda operator. Cell 44, 681-687.
13. 13. Lerner L.J. and Jordan V.C. (1990) Development of antiestrogens and their use in breast cancer: Eighth Cain Memorial Lecture. Cancer Res. 50, 4177-4189.
14. 14. Jordan V.C. (1984) Biochemical pharmacology of antiestrogen action. Pharmac. Rev. 36, 245-276.
15. 15. Katzenellenbogen B.S., Norman M.J., Eckert R.L., Peltz S.W. and Mangel W.F. (1984) Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells. Cancer Res. 44, 112-119.
16. 16. Harlow K.W., Smith D.N., Katzenellenbogen J.A., Green G.A. and Katzenellenbogen B.S. (1989) Identification of cysteine, 530 as the covalent attachment site of an affinity-labeling estrogen (ketononestrol aziridine)and antiestrogen (tamoxifen aziridine) in the human estrogen receptor. J. Biol. Chem. 264, 17476-17485.
17. 17. Danielian P.S., White R., Hoare S.A., Fawell S.E. and Parker M.G. (1993) Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen. Molec. Endocr. 7, 232-240.
18. 18. Robertson D.W., Wei L.L., Hayes J.R., Carlson K.E., Katzenellenbogen J.A. and Katzenellenbogen B.S. (1981) Tamoxifen aziridines: effective inactivators of the estrogen receptor. Endocrinology 109, 1298-1300.
19. 19. Hansen J.C. and Gorski J. (1986) Conformational transitions of the estrogen receptor monomer. Effects of estrogens, antiestrogen, and temperature. J. Biol. Chem. 261, 13990-13996.
20. 20. Giambiagi N. and Pasqualini J.R. (1988) Immunological differences between the estradiol-, tamoxifen- and 4-hydroxytamoxifen- strogen receptor complexes detected by two monoclonal antibodies. J. Steroid Biochem. 30, 213-217.
21. 21. Ruh M.F., Turner J.W., Paulson C.M. and Ruh T.S. (1990) Differences in the form of the salt transformed estrogen receptor when bound by estrogen versus antiestrogen. J. Steroid Biochem. 36, 509-516.
22. 22. Lees J.A., Fawell S.E. and Parker M.G. (1989) Identification of constitutive and steroid-dependent transactivation domains in the mouse oestrogen receptor. J. Steroid Biochem. 34, 33-39.
23. 23. Brown M. and Sharp P.A. (1990) Human estrogen receptor forms multiple protein-DNA complexes. J. Biol. Chem. 265, 11238-11243.
24. 24. Klinge C.M., Peale F.V., Hilf R., Bambara R.A. and Zain S. (1992) Cooperative estrogen receptor interaction with consensus or variant estrogen response elements in vitro. Cancer Res. 52, 1073-1081.
25. 25. Ludwig L.B., Klinge C.M., Peale F.V., Jr., Bambara R.A., Zain S. and Hilf R. (1990) A microtiter well assay for quantitave measurement of estrogen receptor binding to estrogen-responsive elements. Molec. Endocr. 4, 1027-1033.
26. 26. Peale F.V., Jr., Ishibe Y., Klinge C.M., Zain S., Hilf R. and Bambara R.A. (1989) Rapid purification of the estrogen receptor by sequencespecific DNA affinity chromatography. Biochemistry 28, 8671-8675.
27. 27. Sambrook J., Fritsch E. F. and Maniatis T.: Molecular Cloning, Second Edition. Cold Spring Harbor Laboratory Press, New York (1989).
28. 28. Brenowitz M., Senear D.F., Shea M.A. and Ackers G.K. (1986) "Footprint" titrations yield valid thermodynamic isotherms. Proc. Natl. Acad. Sci. U.S.A. 83, 8462-8466.
29. 29. Murdoch F.E., Meier D.A., Furlow D.F., Grunwald K.A.A. and Gorski J. (1990) Estrogen receptor binding to a DNA response element in vitro is not dependent upon estradiol. Biochemistry 29, 8377-8385.
30. 30. Curtis S. and Korach K. (1990) Uterine estrogen receptor interaction with estrogen-responsive DNA sequences in vitro: effects of ligand binding on receptor-DNA complexes. Molec. Endocr. 4, 276-286.
31. 31. Landel C.C., Kushner P.J. and Greene G.L. (1994) The interaction of human estrogen receptor with DNA is modulated by receptor associated proteins. Molec. Endocr. 8, 1407-1419.
32. 32. Greene G.L. and Press M.F. (1986) Structure and dynamics of the estrogen receptor. J. Steroid Biochem. 24, 1-7.
33. 33. Ausubel M. ed.: Current Protocols in Molecular Biology, Vols 1 and 2, Suppl. 8. Greene Pub. Assoc. and Wiley Interscience, New York (1987).
34. 34. Fritsch M., Leary C.M., Furlow J.D., Ahrens H., Schuh T.J., Mueller G.G. and Gorski J. (1992) A ligand induced conformational change in the estrogen receptor is localized in the steroid binding domain. Biochemistry 31, 5303-5311.
35. 35. Bracco L., Kotlarz D., Kolb A., Diekniann S. and Buc H. (1989) Synthetic curved DNA sequences can act as transcriptional activators in Escherichia coli. EMBO J. 8, 4289-4296.
36. 36. Giese K., Cox J. and Grosschedl R. (1992) The HMG domain of lymphoid enhancer factor 1 binds DNA and facilitates assembly of functional nucleoprotein structures. Cell 69, 185-195.
37. 37. Wang Y. and Sauerbier W. (1989) Flanking AT-rich sequences may lower the activation energy of cruciform extrusion in supercoiled DNA. Biochem. Biophys. Res. Commun. 158, 423-431.
38. 38. Sabbah M., Le Ricousse S., Redeuilli G. and Baulieu E.E. (1992) Estrogen receptor-induced bending of the Xenopus vitellogenin A2 gene hormone response element. Biochem. Biophys. Res. Commun. 185, 944-952.
39. 39. Nardulli A.M. and Shapiro D.J. (1992) Binding of the estrogen receptor DNA binding domain to the estrogen response element induces DNA bending. Molec. Cell. Biol. 12, 2037-2042.
40. 40. Nardulli A.M., Greene G.L. and Shapiro D.J. (1993) Human estrogen receptor bound to an estrogen response element bends DNA. Molec. Endocr. 7, 331-340.
41. 41. Nardulli A.M., Grobner C. and Cotter D. (1995) Estrogen receptor-induced DNA bending: orientation of the bend and replacement of an estrogen response element with an intrinsic DNA bending sequence. Molec. Endocr. 9, 1064-1076.
42. 42. Metzger D., Berry M., Ali S. and Chambon P. (1995) Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo. Molec. Endocr. 9, 579-591.
43. 43. Furlow J.D., Murdoch F.E. and Gorski J. (1993) High affinity binding of the estrogen receptor to a DNA response element does not require homodimer formation or estrogen. J. Biol. Chem. 268, 12519-12525.
44. 44. Gorski J., Furlow J.D., Murdoch F.E., Fritsch M., Kaneko K., Ying C. and Malayer J. (1993) Perturbations in the model of estrogen receptor regulation of gene expression. Biology of Reproduction 48, 8-14.
45. 45. Kato S., Tora L., Yamauchi J., Masushige S., Bellard M. and Chambon P. (1992) A far upstream estrogen response element of the ovalbumin gene contains several half-palindromic 5′-TGACC-3′motifs acting synergistically. Cell 68, 731-742.
46. 46. Fried M. and Crothers D.M. (1981) Equilibria and kinetics of lac represser-operator interactions by polyacrylamide gel electrophoresis. Nucl. Acids Res. 9, 6505-6524.
47. 47. Kato S., Haruna S., Suzawa M., Shoichi M., Tora L., Chambon P. and Gronemeyer H. (1995) Widely spaced, directly repeated PuGGTCA elements act as promiscuous enhancers for different classes of nuclear receptors. Molec. Cell. Biol. 15, 5858-5867.
48. 48. Pongilikitmongkol N., White J.H. and Chambon P. (1990) Synergistic activation of transcription by the human estrogen receptor bound to tandem responsive elements. EMBO J. 9, 2221-2231.
49. 49. Martinez E., Givel F. and Wahli W. (1987) The estrogen responsive element as an inducible enhancer: DNA sequence requirements and conversion to a glucocorticoid-responsive element.. EMBO J. 6, 3719-3727.
50. 50. Kumar V., Green S., Staub A. and Chambon P. (1986) Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. EMBO J. 5, 2231-2236.
51. 51. Theulaz I., Hipskind R., Heggler-Bordier B., Green S., Kumar V, Chambon P. and Wahli W. (1988) Expression of human estrogen receptor mutants in Xenopus oocytes: correlation between transcriptional activity and ability to form protein-DNA complexes. EMBO J. 7, 1653-1660.
52. 52. Gronemeyer H. (1991) Transcription activation by estrogen and progesterone receptors. Ann. Rev. Genet. 25, 89-123.
53. 53. Reese J.C. and Katzenellenbogen B.S. (1991) Differential DNA binding abilities of estrogen receptor occupied with two classes of antiestrogens: studies using human receptor overexpressed in mammalian cells. Nucl. Acids Res. 19, 6595-6602.
54. 54. Zhuang Y., Katzenellenbogen B.S. and Shapiro D.J. (1995) Estrogen receptor mutants which do not bind 17β-estradiol dimerize and bind to the estrogen response element in vivo. Molec. Endocr. 9, 457-466.
55. 55. Xing H. and Shapiro D.J. (1993) An estrogen receptor mutant exhibiting hormone-independent transactivation an enhanced affinity for the estrogen response element. J. Biol. Chem. 268, 23227-23233.
56. 56. Halachmi S., Marden E., Martin G., MacKay H., Abbondanza C. and Brown M. (1994) Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264, 1455-1458.
57. 57. Cavailles V., Dauvois P.S., Danielian P.S. and Parker M.G. (1994) Interaction of proteins with transcriptionally active estrogen receptors. Proc. Natl. Acad. Sci. U.S.A. 91, 10009-100013.